Peoria、ILにおける非小細胞肺癌の臨床試験
Peoriaとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する21件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
被験者募集中第3相
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9マイル先
- Illinois CancerCare-Canton, Canton · 25マイル先
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9マイル先
- Illinois CancerCare-Canton, Canton · 25マイル先
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
被験者募集中第2相
- Illinois CancerCare-Peoria, Peoria
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria
- OSF Saint Francis Medical Center, Peoria
- 他3件
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
被験者募集中第2/3相
- OSF Saint Francis Medical Center, Peoria
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
被験者募集中第3相
- Illinois Cancer Care ( Site 7000), Peoria
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
被験者募集中第3相
- Illinois Cancer Care, Peoria
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
被験者募集中第3相
- Illinois Cancer Care, Peoria
- Illinois CancerCare- Pekin, Pekin · 9マイル先
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
被験者募集中第3相
- Illinois CancerCare, P.C., Peoria
- Illinois CancerCare-Pekin, Pekin · 9マイル先
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Illinois CancerCare, Peoria
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
被験者募集中第2相
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 9マイル先
- 他1件
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
被験者募集中第3相
- OSF Saint Francis Medical Center, Peoria
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
被験者募集中第1相
- OSF Health Care, Peoria
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
被験者募集中第1相
- OSF Saint Francis Medical Center, Peoria
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
被験者募集中第1相
- OSF Healthcare System; Saint Francis Medical Center, Peoria
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
被験者募集中第1相
- St. Francis Medical Center (OSF Healthcare), Peoria
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
被験者募集中第2相
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9マイル先
- Illinois CancerCare-Canton, Canton · 25マイル先
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
被験者募集中第1相
- OSF Healthcare Cancer Institute, Peoria
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9マイル先
- Illinois CancerCare-Canton, Canton · 25マイル先
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2/3相
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9マイル先
- Illinois CancerCare-Canton, Canton · 25マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9マイル先
- Illinois CancerCare-Canton, Canton · 25マイル先
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9マイル先
- Illinois CancerCare-Canton, Canton · 25マイル先
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
Peoriaにおける他の研究
- 肺がん12件の研究
- 大腸癌12件の研究
- 前立腺がん9件の研究
- 乳がん8件の研究
- 心不全8件の研究
- 膵臓がん7件の研究
- 卵巣がん7件の研究
- 頭頸部扁平上皮癌7件の研究
- 転移性癌7件の研究
- がん（全種類）7件の研究
- 急性骨髄性白血病6件の研究
- 悪性黒色腫6件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。